Molecular characterisation of a panel of human ovarian carcinoma xenografts

被引:17
|
作者
Codegoni, AM
Nicoletti, MI
Buraggi, G
Valoti, G
Giavazzi, R
D'Incalci, M
Landoni, F
Maneo, A
Broggini, M
机构
[1] Mario Negri Inst Pharmacol Res, I-20157 Milan, Italy
[2] Mario Negri Inst Pharmacol Res, I-24125 Bergamo, Italy
[3] Univ Milan, Osped San Gerardo, Monza, MI, Italy
关键词
ovarian cancer; xenografts; cell cycle proteins; DNA repair; drug resistance;
D O I
10.1016/S0959-8049(98)00075-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In a panel of 16 human ovarian tumours transplanted in nude mice, the expression of genes involved in cell cycle regulation and in response to drug treatment were characterised. In the 16 tumours analysed we could not detect overexpression of Erb-B2 oncogene while expression of MDR1 mRNA was not detected in 11/15 samples and was low in 4/15 tumours. Only three tumours had mutations in the p53 gene exons 5-8 and one of these mutations did not result in any amino acid alteration. The levels of mRNA for cyclins A, D1 and E were heterogeneous with some tumours expressing high levels and others not expressing them at all. The same was found for the cyclin dependent kinases (CDK) CDK2 and CDK4 and for CDK inhibitors P21/WAF1, p27/KIP1 and p16/CDKN2. Two genes belonging to the nucleotide excision repair, ERCC1 and ERCC3 were detectable in all the samples examined, as were the genes MGMT and MAG, also involved in DNA repair. The data indicate a heterogeneity in the expression of genes considered to be involved in the cellular responses to cytotoxic drug treatment and indicate the possibility of using these tumour models to test specifically molecules with a defined mechanism of action. (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1432 / 1438
页数:7
相关论文
共 50 条
  • [31] REVERSAL OF CISPLATINUM (CDDP) RESISTANCE BY CYCLOSPORIN-A (CSA) IN XENOGRAFTS OF FRESH HUMAN OVARIAN-CARCINOMA
    STRATTON, JA
    DISAIA, PJ
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 479 - 479
  • [32] THE ESTABLISHMENT, CHARACTERIZATION AND CALIBRATION OF HUMAN OVARIAN-CARCINOMA XENOGRAFTS FOR THE EVALUATION OF NOVEL PLATINUM ANTICANCER DRUGS
    HARRAP, KR
    JONES, M
    SIRACKY, J
    POLLARD, LA
    KELLAND, LR
    ANNALS OF ONCOLOGY, 1990, 1 (01) : 65 - 76
  • [33] SUCCESSFUL LOCAL-REGIONAL THERAPY WITH TOPOTECAN OF INTRAPERITONEALLY GROWING HUMAN OVARIAN-CARCINOMA XENOGRAFTS
    PRATESI, G
    TORTORETO, M
    CORTI, C
    GIARDINI, R
    ZUNINO, F
    BRITISH JOURNAL OF CANCER, 1995, 71 (03) : 525 - 528
  • [34] Cediranib Affects Tumor Progression and Survival of Mice Bearing Human Ovarian Carcinoma Xenografts Expressing VEGFC
    Decio, A.
    Cesca, M.
    Scarlato, V.
    Juergensmeier, J. M.
    Taraboletti, G.
    Giavazzi, R.
    Belotti, D.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S226 - S226
  • [35] Extragonadal ovarian carcinoma: Molecular characterization and comparison to ovarian carcinoma
    Kanbour, A
    Kawalski, L
    KanbourShakir, A
    Kounelis, S
    Papadaki, H
    Raptis, S
    Bakker, A
    Swalsky, PA
    Edwards, RP
    Finkelstein, SD
    LABORATORY INVESTIGATION, 1996, 74 (01) : 531 - 531
  • [36] CHEMOTHERAPY OF HUMAN BREAST-CARCINOMA XENOGRAFTS
    BAILEY, MJ
    GAZET, JC
    SMITH, IE
    STEEL, GG
    BRITISH JOURNAL OF CANCER, 1980, 42 (04) : 530 - 536
  • [37] OVARIAN TUMOR XENOGRAFTS IN THE STUDY OF THE BIOLOGY OF HUMAN EPITHELIAL OVARIAN-CANCER
    FRIEDLANDER, ML
    RUSSELL, P
    TAYLOR, IW
    TATTERSALL, MHN
    BRITISH JOURNAL OF CANCER, 1985, 51 (03) : 319 - 333
  • [38] XENOGRAFTS OF PRIMARY HUMAN PROSTATIC-CARCINOMA
    PRETLOW, TG
    WOLMAN, SR
    MICALE, MA
    PELLEY, RJ
    KURSH, ED
    RESNICK, MI
    BODNER, DR
    JACOBBERGER, JW
    DELMORO, CM
    GIACONIA, JM
    PRETLOW, TP
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) : 394 - 402
  • [39] Human breast carcinoma xenografts in nude mice
    Li, ZH
    Huang, XF
    Li, JY
    Ke, Y
    Yang, LG
    Wang, YX
    Yao, LH
    Lü, YW
    CHINESE MEDICAL JOURNAL, 2002, 115 (02) : 222 - 226
  • [40] Molecular characterization of a panel of patient-derived breast cancer xenografts
    Giesemann, Torsten
    Krumbach, Rebekka
    Schiller, Julia
    Vuaroqueaux, Vincent
    Hofmann, Michael
    Liu, Ningshu
    Haegebarth, Andrea
    Beckers, Thomas
    Fiebig, Heinz-Herbert
    CANCER RESEARCH, 2010, 70